Article Text

Download PDFPDF
Images in paediatrics
Cutaneous larva migrans in a temperate area
  1. Anca Chiriac1,2,
  2. Anca E Chiriac3,
  3. Tudor Pinteala3,
  4. Cristian Podoleanu4,
  5. Marius Florin Coros5,
  6. Cosmin Moldovan6,
  7. Simona Stolnicu7
  1. 1 Department of Dermatology, Nicolina Medical Center, Iasi, Romania
  2. 2 Department of Dermato-Physiology, Apollonia University, Iasi, Romania
  3. 3 “Gr. T. Popa” University of Medicine and Pharmacy, Iasi, Romania
  4. 4 Department of Cardiology, University of Medicine and Pharmacy of Targu-Mures, Targu-Mures, Romania
  5. 5 Department of Surgery, University of Medicine and Pharmacy of Targu-Mures, Targu-Mures, Romania
  6. 6 Department of Histology, University of Medicine and Pharmacy of Targu-Mures, Targu-Mures, Romania
  7. 7 Department of Pathology, University of Medicine and Pharmacy of Targu-Mures, Targu-Mures, Romania
  1. Correspondence to Professor Marius Florin Coros, Department of Surgery, University of Medicine and Pharmacy of Targu-Mures, 38 Gheorghe Marinescu Street, Targu Mures, Mures 540139, Romania; corosmarius1{at}gmail.com

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Cutaneous larva migrans (CLM) is common in children in tropical and subtropical areas but exceptionally rare in temperate zones.1 We report a case of CLM in a child from a temperate climate country.

An 8-year-old boy was seen with a facial skin eruption. The boy lived in an industrialised city in Romania, but spent 2 months of his summer holidays in a rural village, 150 km away, playing with cats and dogs. Initial pruritus on the left cheek was followed by progressive serpiginous erythematous papules along the left aspect of …

View Full Text

Footnotes

  • Contributors AC: made the clinical diagnosis and treated the patient; drafting the article and revising it critically for important intellectual content; final approval of the version to be published. AEC, TP and CP: substantial contributions to the acquisition of data from the international literature and analysis and interpretation of the data; critical revision of the draft for important intellectual content; final approval of the version to be published. MFC: prepared the document for submission; critical revision of the draft for important intellectual content; final approval of the version to be published. CM: improved the quality of the picture and translated the text; critical revision of the draft for important intellectual content; final approval of the version to be published. SS: substantial contributions to the study's conception and design and data interpretation; drafting the article and revising it critically for important intellectual content; final approval of the version to be published.

  • Competing interests None declared.

  • Patient consent Parental/guardian consent obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.